About
About BioFutureRx
BioFutureRx is a biopharmaceutical company focused on biologic medicines — spanning biosimilars, antibodies, diagnostics, and delivery platforms — and it engineers its own peptide therapeutics in-house, led by its lead asset, BFRx3711. Our team brings decades of combined experience in drug development, biologics, and the partnerships that bring new medicines to patients.
Our Team
The team behind the science
Rob Camerer
Chairman & Managing Director
Rob leads BioFutureRx's strategy across its focus on biologic medicine and its in-house peptide program, drawing on decades in pharmaceutical development and business development. He directs the company's mission to advance biologic medicine and its own peptide therapeutics for patients.
View profile
Dr. Gopal Venkatesan
Chief Executive Officer
Gopal leads the scientific development of BioFutureRx's pipeline, pairing deep technical insight with development experience. He directs the company's biologics and peptide-design work — including development strategy for BFRx3711 — from molecular engineering and preclinical science through regulatory pathway.
View profile
Dr. Juncai (Chris) Bai
Board Member
Dr. Bai brings decades of peptide drug-development and cGMP manufacturing leadership to the BioFutureRx board. He is the Founder, Chairman, and Chief Executive Officer of Ambio, and previously served as President and CEO of American Peptide Company.
View profile
Jonathan Camerer
Director of Business Development
Jonathan manages BioFutureRx's corporate development and program operations, guiding the company's partnering and financing discussions from first contact through structured agreements.
View profile
Joshua Camerer
Business Development Manager
Joshua drives front-line business development — managing outreach to prospective strategic partners and investors and supporting the financing of BioFutureRx's programs.
View profile